Australians that are struggling to get a good night sleep can now screen their likelihood of suffering from sleep apnoea with medtech company ResApp Health (ASX: RAP) having launched their clinically tested SleepCheck app on the iPhone App Store. By downloading the smartphone app, SleepCheck can record and analyse breaking and snorting sounds during sleep
Read More
Health tech company MyFiziq (ASX: MYQ) has partnered with Canadian firm NuraLogix which will leverage the two company’s patented imaging technology. Using a smartphone camera, transdermal imaging and artificial intelligence (AI), the newly combined tech aims to determine a user’s probability of having COVID-19, as well as their risk of developing diseases that result in
Read More
Australian medtech company Mach7 Technologies (ASX: M7T) has continued to strengthen its position in the Hong Kong market, securing new licencing orders of $4.8m, adding to their existing 5-year contract to supply medical imaging solutions to the entire territory of Hong Kong. The new AUD $4.8m is expected to be logged as cash collected within
Read More
Mental health medtech company Medibio (ASX: MEB) has continued its accelerated plans towards FDA approvals under new management with the company having lodged an FDA application overnight for their mental health screening software – MEBsleep. Having collected the required clinical data MEBsleep (previously named STAGER) tested more than 1,000 individuals using Medibio’s sleep staging algorithm
Read More
3D printing medtech company Osteopore (ASX: OSX) is set to continue their successful streak, following news that the company has received Australian Therapeutics Goods Administration (TGA) approval for three craniofacial products, after being placed into a trading halt Friday afternoon. The Osteomesh, Osteoplug, and Osteoplug-C, are used primarily to fill voids in a patient’s bone,
Read More
Under new management, medtech company Respiri (ASX: RSH) is poised to enter the lucrative SaaS revenue market by leveraging their asthma screening device to partner with Phenix Healthcare, whose patients will be able to monitor their condition using Respiri’s wheezo device. The agreement will give Phenix Healthcare’s patients diagnosed with asthma an option to monitor
Read More